Paion's competitors

Paion's competitors include Amicus Therapeutics, Clinigen Group, Mast Therapeutics and Sucampo Pharmaceuticals
Add company...
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Sucampo Pharmaceuticals
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
Founding Date
Founding Date
2000
Founding Date
2002
Founding Date
2010
Founding Date
1995
Founding Date
1996
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Aachen, DE HQ
Locations
Cranbury Township, US HQ
Puteaux, FR
Munich, DE
Amsterdam, NL
Denham, GB
Locations
Burton upon Trent, GB HQ
Locations
San Diego, US HQ
Locations
Rockville, US HQ
Kita Ward, JP
Chiyoda, JP
Chuo Ward, JP
Sanda Shi, JP
Zug, CH
Milton, GB
Employees
Employees
39
Employees
263
Employees
465 200% increase
Employees
14 133% increase
Employees
139
Valuation ($)
Valuation ($)
185.3 m
Valuation ($)
2.4 b
Valuation ($)
1.8 b
Valuation ($)
300 m
Valuation ($)
1.2 b
Twitter followers
Twitter followers
N/A
Twitter followers
741
Twitter followers
1.2 k
Twitter followers
873
Twitter followers
245

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$5m (FY, 2016)
Revenue (est.)
£302.3m (FY, 2017)
Revenue (est.)
$128k (FY, 2016)
Revenue (est.)
$230.1m (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
$833k (FY, 2016)
Cost of goods
£179.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
$76m (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
$4.1m (FY, 2016)
Gross profit
£122.7m (FY, 2017)
Gross profit
N/A
Gross profit
$154.1m (FY, 2016)
Net income
Net income
N/A
Net income
($200m) (FY, 2016)
Net income
£3.8m (FY, 2017)
Net income
($36.1m) (FY, 2016)
Net income
$18.5m (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles